LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Resolvyx Pharmaceuticals Inc.
Headquarters:
Cambridge, MA, United States
Website:
http://www.resolvyx.com
Year Founded:
2004
Status:
Private
BioCentury
|
Nov 30, 2017
Preclinical News
Resolvins keep tumor debris from stimulating tumor growth
Read More
BioCentury
|
Sep 29, 2017
Strategy
Bridge to innovation
Why Chinese biopharmas are building beachheads in Boston
Read More
BioCentury
|
Jul 15, 2013
Company News
Warp Drive Bio management update
Read More
BioCentury
|
Jul 3, 2013
Company News
Warp Drive names Verdine CEO
Read More
BioCentury
|
May 31, 2012
Distillery Therapeutics
Indication: Infectious disease
Read More
BioCentury
|
Jan 17, 2011
Company News
Celtic Therapeutics Holdings L.P., Resolvyx deal
Read More
BioCentury
|
Nov 1, 2010
Company News
Celtic Therapeutics Holdings L.P., Resolvyx deal
Read More
BioCentury
|
Nov 1, 2010
Finance
Celtic's Big Top Off
Celtic Therapeutics nears final fund close; invests in ophthalmic play Resolvyx
Read More
BioCentury
|
Oct 27, 2010
Company News
Resolvyx grants Celtic RX-10045 option
Read More
BioCentury
|
Oct 18, 2010
Company News
Shire management update
Read More
Items per page:
10
1 - 10 of 37